Respiratory Diseases of Adults
暂无分享,去创建一个
Arthur S Slutsky | F. Speizer | J. Batt | S. Horton | Frank E. Speizer | Jane Batt | Susan Horton | Arthur S. Slutsky
[1] J. Scott,et al. Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya , 2000, The Lancet.
[2] A. García de Lorenzo,et al. Mechanical ventilation of patients on long-term oxygen therapy with acute exacerbations of chronic obstructive pulmonary disease: prognosis and cost-utility analysis , 1999, Intensive Care Medicine.
[3] G. Raghu,et al. The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group. , 1995, Chest.
[4] P. O'Malley,et al. Should Health-Care Systems Pay for Replacement Therapy in Patients With α1-Antitrypsin Deficiency? , 2000 .
[5] A. Aaviksoo,et al. Costs of asthma treatment in Estonia. , 2001, European journal of public health.
[6] S. Sullivan,et al. The health economics of asthma and rhinitis. I. Assessing the economic impact. , 2001, The Journal of allergy and clinical immunology.
[7] R. Stelmach,et al. Evaluation of health-related quality of life in low-income patients with COPD receiving long-term oxygen therapy. , 2003, Chest.
[8] M. Raviglione,et al. Global tuberculosis incidence and mortality during 1990-2000. , 1994, Bulletin of the World Health Organization.
[9] W. Bailey,et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. , 2000, American journal of respiratory and critical care medicine.
[10] J. LaDou. The asbestos cancer epidemic. , 2003, Environmental health perspectives.
[11] T. Clemmer,et al. Prolonged mechanical ventilation for respiratory failure: A cost‐benefit analysis , 1983, Critical care medicine.
[12] E. Manor,et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. , 1996, Thorax.
[13] S. Stearns,et al. Reductions in hospital use from self management training for chronic asthmatics. , 1998, Social science & medicine.
[14] E. Doorslaer,et al. Economic appraisal of asthma and COPD care: a literature review 1980-1991. , 1992, Social science & medicine.
[15] K. Weiss,et al. An update on the health economics of asthma and allergy , 2002, Current opinion in allergy and clinical immunology.
[16] A. Ng,et al. A study on community acquired pneumonia in adults requiring hospital admission in Penang. , 2001, The Medical journal of Malaysia.
[17] P A West,et al. Economic evaluation of strategies for the control and management of influenza in Europe. , 2002, Vaccine.
[18] W C Tan,et al. Prospective study of the aetiology of adult community acquired bacterial pneumonia needing hospitalisation in Singapore. , 1993, Singapore medical journal.
[19] J. Hay,et al. Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease. , 1991, American journal of public health.
[20] R. Loewenson. Assessment of the health impact of occupational risk in Africa: current situation and methodological issues. , 1999, Epidemiology.
[21] Barrett T. Kitch,et al. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. , 2001, The Journal of allergy and clinical immunology.
[22] D. Dockery,et al. Chronic obstructive pulmonary disease mortality in six U.S. cities. , 1989, The American review of respiratory disease.
[23] W. Bailey,et al. Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.
[24] J Bousquet,et al. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. , 2001, Bulletin of the World Health Organization.
[25] B. Williams,et al. Occupational lung disease in ex-mineworkers--sound a further alarm! , 1996, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[26] D. Jamison,et al. Disease Control Priorities in Developing Countries , 1993 .
[27] C. van Weel,et al. The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program. , 2001, American journal of respiratory and critical care medicine.
[28] A. Crockett,et al. A review of long-term oxygen therapy for chronic obstructive pulmonary disease. , 2001, Respiratory medicine.
[29] T. Perneger,et al. Objectives, methods and content of patient education programmes for adults with asthma: systematic review of studies published between 1979 and 1998 , 1999, Thorax.
[30] Joel Huber,et al. Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults , 2002, Annals of Internal Medicine.
[31] M. Koopmanschap,et al. Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. , 1998, Chest.
[32] D. Low,et al. SARS--one year later. , 2003, The New England journal of medicine.
[33] A. Hedley,et al. Cost-effectiveness study on influenza prevention in Hong Kong. , 2001, Health policy.
[34] K. R. Smith. National burden of disease in India from indoor air pollution. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Jefferson,et al. Prevention and early treatment of influenza in healthy adults. , 2000, Vaccine.
[36] R. Kaplan,et al. The Costs and Effects of Behavioral Programs in Chronic Obstructive Pulmonary Disease , 1984, Medical care.
[37] F. Chew,et al. The economic cost of asthma in Singapore. , 1999, Australian and New Zealand journal of medicine.
[38] A. Buist. Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.
[39] C. Fletcher. The Natural history of chronic bronchitis and emphysema: An eight-year study of early chronic obstructive lung disease in working men in London , 1976 .
[40] S. Sullivan,et al. Health economics of asthma and rhinitis. II. Assessing the value of interventions. , 2001, The Journal of allergy and clinical immunology.
[41] Alan D. Lopez,et al. The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .
[42] P. Dorinsky,et al. Combination Therapy with Inhaled Long‐Acting β2‐Agonists and Inhaled Corticosteroids: A Paradigm Shift in Asthma Management , 2002, Pharmacotherapy.
[43] A. Morice,et al. Assessing the burden of respiratory disease in the UK. , 2002, Respiratory medicine.
[44] P Macaskill,et al. Global burden of disease and injury due to occupational factors. , 1999, Epidemiology.